Breaking News

Ajinomoto Bio-Pharma Services Gets FDA Approval for High Potency Fill Line

The company has six fill-finish lines that offer a range of configurations, including prefilled syringes, cartridges, and vials.

Ajinomoto Bio-Pharma Services, a provider of biopharmaceutical contract development and manufacturing services, announced that the U.S. Food and Drug Administration (FDA) has approved the company’s high potency vial line to manufacture a commercial product. “Receiving FDA approval on our HPAPI fill line is an exciting milestone for our company, and couldn’t have happened without the hard work, hours of preparation, diligence and support from the Aji Bio-Pharma team across ou...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters